Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rohto Pharmaceutical Co Ltd
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Intangible Assets
ÂĄ8.4B
CAGR 3-Years
34%
CAGR 5-Years
27%
CAGR 10-Years
9%
Shiseido Co Ltd
TSE:4911
Intangible Assets
ÂĄ176.4B
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
6%
Kao Corp
TSE:4452
Intangible Assets
ÂĄ77.5B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
10%
Kose Corp
TSE:4922
Intangible Assets
ÂĄ9.7B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
-1%
F
Fancl Corp
TSE:4921
Intangible Assets
ÂĄ2.3B
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
-3%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Intangible Assets
ÂĄ12.3B
CAGR 3-Years
31%
CAGR 5-Years
50%
CAGR 10-Years
24%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Rohto Pharmaceutical Co Ltd's Intangible Assets?
Intangible Assets
8.4B JPY

Based on the financial report for Sep 30, 2024, Rohto Pharmaceutical Co Ltd's Intangible Assets amounts to 8.4B JPY.

What is Rohto Pharmaceutical Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
9%

Over the last year, the Intangible Assets growth was 21%. The average annual Intangible Assets growth rates for Rohto Pharmaceutical Co Ltd have been 34% over the past three years , 27% over the past five years , and 9% over the past ten years .

Back to Top